It has been estimated that the drug delivery product demand will increase by 7.4% yearly to $134 billion in 2015. Parenteral products will be the fastest growing area, followed by monoclonal antibodies and polymer-encapsulated medicines. Other types expected to do well include prefilled dry powder and metered dose brachytherapy implants, and implantable drug delivery products.
As the industry model moves further from that of the blockbusters, companies are under more pressure than ever to push new compounds through development in an effort to see a return on their investments. Europe has a long standing and loyal consumer market, is home to an elite group of highly profitable pharmaceutical companies and has the technical expertise to drive its growth in this area.
It is now left to those in formulation and delivery to optimise their product portfolio using winning business strategies and leading technologies.
The Global Drug Delivery & Formulation Summit sources and presents leading global case studies from Pfizer, GSK, Novartis, Merck, Eli Lilly and many more. The summit is packed with drug delivery real life case studies, allowing you to benchmark your business approach & technologies against ‘best in class’ and ensure that you have the tools you need to form a coherent and logical strategy.